%0 Journal Article %A Jason Ornstein %A Ray O.K. Ozdemir %A Anne Boehme %A Farid Nouar %A Christian Serre %A Daniel N. Ackerman %A Vicki L. Herrera %A Joshua L. Santarpia %T SARS-CoV-2 Inactivation Potential of Metal Organic Framework Induced Photocatalysis %D 2020 %R 10.1101/2020.10.01.20204214 %J medRxiv %P 2020.10.01.20204214 %X As the world recovers from the lockdown imposed by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic, returning to shared indoor spaces is considered a formidable risk. It is now clear that transmission of SARS-CoV-2 is driven by respiratory microdroplets expelled by infected persons, which can become suspended in the air. Several layering technologies are being explored to mitigate indoor transmission in the hopes of re-opening business, schools and transportation systems. Here we coupled the water adsorptive and photocatalytic capacity of novel Metal Organic Frameworks (MOFs) to demonstrate the capture and inactivation of SARS-CoV-2. Discussion is given on the methods of analysis and the differences between the photocatalytic activity of several MOFs, and the difference between MOF induced photocatalysis and ultra violet photolysis of SARS-CoV-2. Our results are intended to provide support to industry looking for alternative methods secure indoor spaces.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding obtained.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB necessaryAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated or analysed during this study are included in this paper. Material characterization information including the crystallinity raw data is available via contributing authors. %U https://www.medrxiv.org/content/medrxiv/early/2020/10/06/2020.10.01.20204214.full.pdf